Scientists show how we read intentions from one another's gazes
Researchers are curious to gain a deeper understanding of how glances can transmit information during social interactions. (Envato Elements pic)
PARIS : It's often said the eyes are the mirror of the soul. Another well-known phrase is: 'I see it in your eyes.' This reflects the fact that sight is the predominant human sense: we have a natural tendency to scrutinise the eyes of others, seeking to detect their emotions or intentions.
With this in mind, researchers at McGill University in Montreal, Canada, have studied how our eyes can convey our intentions, without the need for words.
To gain a deeper understanding of how glances can transmit information in social interactions, Jelena Ristic and colleagues conducted a series of experiments involving between 70 and 80 volunteers, who watched videos of people turning their gaze to the left or right.
Sometimes these eye movements were spontaneous, other times deliberately provoked. The videos stopped just before the movement took place, and the participants had to guess in which direction the eyes were going to move.
The scientists found that the rate of correct responses remained stable, but the speed of the responses increased when the eye movement was intentional, i.e. when the people on screen were free to choose the direction of their gaze.
'The speed of the observers' responses suggests that they implicitly recognise and respond more quickly to intentional eye movements. It also told us how sensitive we are to information about the mental state and intentions conveyed by the eyes,' says Florence Mayrand, a PhD candidate and the paper's first author.
In other words, participants were able to glean intentions in the eyes before any action had taken place. To explain this phenomenon, the researchers examined the micro-movements that preceded eye movements in the videos.
In the journal Communications Psychology, they observed that intentional gazes were accompanied by greater activity around the eyes, reflecting the existence of particular movement patterns. It's this subtle movement that our brains instinctively pick up on, as a kind of invisible sign of intention.
In the future, the scientists plan to accurately measure the speed, trajectory and frequency of blinking in intentional and directed looks. They would also like to determine whether these properties vary according to intention (lying, helping, fleeing), or whether sensitivity to intentions in gaze might differ in people with social difficulties, such as individuals with autism or ADHD.
There's nothing magical about reading people's eyes; it's a skill deeply rooted in us, essential to the survival of our ancestors, and still at work in our daily interactions.
Behind every shift in the gaze, an intention takes shape, and our brains often know how to decipher these intentions – without us even being aware of it.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
04-06-2025
- Malay Mail
Fearing AI misuse, tech godfather Bengio sets up group to monitor rogue agents that could ‘greatly harm humanity'
NEW YORK, June 4 — Concerned about the rapid spread of generative AI, a pioneer researcher is developing software to keep tabs on a technology that is increasingly taking over human tasks. Canadian computer science professor Yoshua Bengio is considered one of the godfathers of the artificial intelligence revolution and on Tuesday announced the launch of LawZero, a non-profit organisation intended to mitigate the technology's inherent risks. The winner of the Turing Award, also known as the Nobel Prize for computer science, has been warning for several years of the risks of AI, whether through its malicious use or the software itself going awry. Those risks are increasing with the development of so-called AI agents, a use of the technology that tasks computers with making decisions that were once made by human workers. The goal of these agents is to build virtual employees that can do practically any job a human can, at a fraction of the cost. 'Currently, AI is developed to maximise profit,' Bengio said, adding it was being deployed even as it persists to show flaws. Every frontier AI system should be grounded in a core commitment: to protect human joy and endeavour. Today, we launch @LawZero_, a nonprofit dedicated to advancing safe-by-design AI. June 3, 2025 Moreover, for Bengio, giving AI human-like agency will easily be used for malicious purposes such as disinformation, bioweapons, and cyberattacks. 'If we lose control of rogue super-intelligent AIs, they could greatly harm humanity,' he said. One of the first objectives at LawZero will be to develop Scientist AI, a form of specially trained AI that can be used as a guardrail to ensure other AIs are behaving properly, the company said. The organisation already has over 15 researchers and has received funding from Schmidt Sciences, a charity set up by former Google boss Eric Schmidt and his wife Wendy. The project comes as powerful large language models (or LLMs) from OpenAI, Google and Anthropic are deployed across all sectors of the digital economy, while still showing significant problems. These include AI models that show a capability to deceive and fabricate false information even as they increase productivity. In a recent example, AI company Anthropic said that during safety testing, its latest AI model tried to blackmail an engineer to avoid being replaced by another system. — AFP
Free Malaysia Today
03-06-2025
- Free Malaysia Today
New hope for patients with less common breast cancer
Results from a new study could soon establish a new first-line therapy for people with HER2-positive metastatic breast cancer. (Envato Elements pic) WASHINGTON : A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't seen major drug advances in over a decade, researchers reported Monday. Results from the study, presented at the annual meeting of the American Society for Clinical Oncology, are expected to be submitted to regulators and could soon establish a new first-line therapy for people with HER2-positive metastatic breast cancer – the advanced stage of a form that comprises 15–20% of all breast cancer cases. HER2-positive cancers are fuelled by an overactive HER2 gene, which makes too much of a protein called human epidermal growth factor receptor 2 that helps cancer cells grow and spread. Patients with HER2-positive breast cancer that has spread to other parts of the body live around five years. 'Seeing such a striking improvement was really impressive to us – we were taking a standard and almost doubling how long patients could have their cancer controlled for,' oncologist Sara Tolaney, chief of the breast oncology division at Dana-Farber Cancer Institute, told AFP. The current standard of care, known as THP, combines chemotherapy with two antibodies that block growth signals from the HER2 protein. The new approach uses a drug called trastuzumab deruxtecan (T-DXd), an antibody attached to a chemotherapy drug. 'Smart bomb' This 'smart bomb' strategy allows the drug to target cancer cells directly. 'You can bind to the cancer cell and dump all that chemo right into the cancer cells,' explained Tolaney. 'Some people call them smart bombs because they're delivering chemo in a targeted fashion – which is how I think we're able to really increase efficacy so much.' Common side effects included nausea, diarrhea and a low white blood cell count, with a less common effect involving lung scarring. T-DXd is already approved as a 'second-line' option – used when first-line treatments stop working. But in the new trial, it was given earlier, paired with another antibody, pertuzumab. In a global trial led by Tolaney, just under 400 patients were randomly assigned to receive T-DXd in combination with pertuzumab, thought to enhance its effects. A similar number received the standard THP regimen. A third group, who received T-DXd without pertuzumab, was also enrolled — but those results haven't yet been reported. 44% risk reduction At a follow-up of 2.5 years, the T-DXd and pertuzumab combination reduced the risk of disease progression or death by 44% compared to standard care. Meanwhile, 15% of patients in the T-DXd group saw their cancer disappear entirely, compared to 8.5% in the THP group. Because this was an interim analysis, the median progression-free survival – meaning the point at which half the patients had seen their cancer return or worsen – was 40.7 months with the new treatment, compared to 26.9 months with the standard, and could rise further as more data come in. Tolaney said the results would be submitted to regulators around the world, including the US Food and Drug Administration, and that future work would focus on optimizing how long patients remain on the treatment, particularly those showing complete remission. 'This represents a new first-line standard treatment option for HER2-positive metastatic breast cancer,' said Dr. Rebecca Dent, a breast cancer specialist at the National Cancer Center Singapore who was not involved in the study
Free Malaysia Today
01-06-2025
- Free Malaysia Today
Zuckerberg says Meta AI bot used a billion times monthly
Google revealed AI Overviews has grown to over 1.5 billion users since debuting in search results last year. (Reuters pic) CALIFORNIA : Meta chief Mark Zuckerberg touted the tech firm's generative artificial intelligence (Gen AI) assistant on Wednesday, telling shareholders it is used by a billion people each month across its platforms. Zuckerberg noted the milestone anew at Meta's annual gathering of shareholders and as the social media behemoth vies with Google, Microsoft, OpenAI and others to be a leader in Gen AI. It was not clear how much Meta AI use involved people seeking out the chatbot versus passive users of Meta AI, as it is built into features in its family of apps. Since Google debuted AI Overviews in search results a year ago, it has grown to more than 1.5 billion users, according to Google chief executive Sundar Pichai. 'That means Google Search is bringing Gen AI to more people than any other product in the world,' Pichai said. Google's AI Overviews are automatically provided summaries of search results that appear instead of the previous practice of simply showing pages of blue links to revelant websites. Pichai said last week that Google's dedicated Gemini AI app has more than 400 million monthly users. Tech rivals are rapidly releasing new AI products despite ongoing challenges with preventing misinformation and establishing clear business models, and little sense of how the tech will affect society. Meta unveiled its first standalone AI assistant app on April 29, giving users a direct path to its Gen AI models. 'A billion people are using Meta AI across our apps now, so we made a new standalone Meta AI app for you to check out,' Meta CEO and founder Mark Zuckerberg said in a video posted on Instagram at the time. Zuckerberg said the app 'is designed to be your personal AI' and would be primarily accessed through voice conversations with the interactions personalized to the individual user. Use of Meta AI is growing fastest on WhatsApp, according to chief financial officer Susan Li. 'Our focus for this year is deepening the experience and making Meta AI the leading personal AI,' Zuckerberg said when Meta announced quarterly earnings at the end of April.
